Gene · 4118
Papers2,902
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,902
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shedding light on the molecular and regulatory mechanisms of TLR4 signaling in endothelial cells under physiological and inflamed conditions. | Front Immunol | 2023 | 38077393 | PubTator, text mining | PubMed |
| Molecular Signatures Integral to Natural Reprogramming in the Pigment Epithelium Cells after Retinal Detachment in Pleurodeles waltl. | Int J Mol Sci | 2023 | 38069262 | PubTator, text mining | PubMed |
| Diversity and Classification of Genetic Variations in Autism Spectrum Disorder. | Int J Mol Sci | 2023 | 38069091 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance. | Cancers (Basel) | 2023 | 38067255 | PubTator, text mining | PubMed |
| POU5F1 promotes the proliferation, migration, and invasion of gastric cancer cells by reducing the ubiquitination level of TRAF6. | Cell Death Dis | 2023 | 38062041 | PubTator, text mining | PubMed |
| PAIRWISE NONLINEAR DEPENDENCE ANALYSIS OF GENOMIC DATA. | Ann Appl Stat | 2023 | 38046186 | PubTator, text mining | PubMed |
| Small molecule modulators of immune pattern recognition receptors. | RSC Chem Biol | 2023 | 38033733 | PubTator, text mining | PubMed |
| COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series. | RMD Open | 2023 | 38030231 | PubTator, text mining | PubMed |
| Are there ancient editions of Paul's letters?: The Euthalian apparatus as a storehouse of tradition. | Stud Theol | 2023 | 38020802 | PubTator, text mining | PubMed |
| Term-BLAST-like alignment tool for concept recognition in noisy clinical texts. | Bioinformatics | 2023 | 38001031 | PubTator, text mining | PubMed |
| Role of Stress on Driving the Intestinal Paracellular Permeability. | Curr Issues Mol Biol | 2023 | 37998758 | PubTator, text mining | PubMed |
| Tight Junction Claudins and Occludin Are Differentially Regulated and Expressed in Genomically Defined Subsets of Colon Cancer. | Curr Issues Mol Biol | 2023 | 37998722 | PubTator, text mining | PubMed |
| The impact of Chinese adolescents visual art participation on self-efficacy: A serial mediating role of cognition and emotion. | PLoS One | 2023 | 37992032 | PubTator, text mining | PubMed |
| Broad-spectrum metastasis suppressing compounds and therapeutic uses thereof in human tumors. | Sci Rep | 2023 | 37990044 | PubTator, text mining | PubMed |
| Radiotranscriptomics identified new mRNAs and miRNA markers for distinguishing prostate cancer from benign prostatic hyperplasia. | Cancer Med | 2023 | 37987209 | PubTator, text mining | PubMed |
| Overdosevarslingssystemer – en kartleggingsoversikt med maskinlæring. | Nordisk Alkohol Nark | 2023 | 37969899 | PubTator, text mining | PubMed |
| Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia. | Res Sq | 2023 | 37961674 | PubTator, text mining | PubMed |
| Whole genome sequencing in high-grade cervical intraepithelial neoplasia patients from different ethnic groups in China. | Medicine (Baltimore) | 2023 | 37960754 | PubTator, text mining | PubMed |
| Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges. | Cancers (Basel) | 2023 | 37958473 | PubTator, text mining | PubMed |
| Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies. | Front Oncol | 2023 | 37954086 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4118/papers?page=7